EMBO announces newest elected members
EMBO has bestowed upon 63 leading scientists the lifetime honour of EMBO Membership in recognition of their remarkable achievements in the life sciences, it was announced today.
EMBO has bestowed upon 63 leading scientists the lifetime honour of EMBO Membership in recognition of their remarkable achievements in the life sciences, it was announced today.
EMBO announces an extension of its current Short-Term Fellowship scheme: Core Facility Fellowships. These fellowships will support exchanges of technology and expertise between core research facilities that provide services to research institutions or universities.
EMBO and FEBS announce Elly Tanaka of the Research Institute of Molecular Pathology, Vienna BioCenter, Austria, as the recipient of the FEBS | EMBO Women in Science Award 2020.
EMBO is pleased to announce that eleven life scientists have been selected to receive Installation Grants, which will support them in establishing independent laboratories in the Czech Republic, Poland, Portugal and Turkey.
Multi-journal partnership aims to accelerate scientific publishing by offering journal-independent peer review
Nine life scientists join the new EMBO Programme in its first year
MALT1 blockers have long been in clinical use for the treatment of blood cancers. A study suggests that these drugs could potentially also be developed as a treatment option for glioblastoma, the most common and lethal type of brain tumour.
EMBO Press is pleased to announce the appointment of systems biologist M. Madan Babu as the new Chief Editor of Molecular Systems Biology.
EMBO congratulates twenty-seven life scientists on their selection as new EMBO Young Investigators.
The Israeli Acute Paralysis Virus is a pathogen that affects honey bees and has been linked to Colony Collapse Disorder, a key factor in decimating the bee population.